7137-38-4 Usage
Chemical structure
1-(3-chloro-2-nitrophenyl)ethanone is a chemical compound consisting of a benzene ring with a chlorine and a nitro group attached to it, as well as an ethanone group.
Usage
It is typically used in organic synthesis and can also be utilized as a building block for the synthesis of various pharmaceuticals and agrochemicals.
Safety
It is important to handle 1-(3-chloro-2-nitrophenyl)ethanone with caution as it may be hazardous to health and the environment, and appropriate safety measures should be taken when working with it.
Physical properties
The specific physical properties such as melting point, boiling point, density, and solubility are not provided in the material.
Chemical properties
The specific chemical properties such as reactivity, stability, and chemical formula are not provided in the material.
Hazardous nature
The compound may be hazardous to health and the environment, indicating that it could potentially cause harm if not handled properly.
Precaution
Appropriate safety measures should be taken when working with 1-(3-chloro-2-nitrophenyl)ethanone, suggesting the use of protective gear and following safety protocols.
Check Digit Verification of cas no
The CAS Registry Mumber 7137-38-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,1,3 and 7 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 7137-38:
(6*7)+(5*1)+(4*3)+(3*7)+(2*3)+(1*8)=94
94 % 10 = 4
So 7137-38-4 is a valid CAS Registry Number.
7137-38-4Relevant academic research and scientific papers
SMALL MOLECULE INHIBITORS OF CANCER STEM CELLS AND MESENCHYMAL CANCER TYPES
-
Paragraph 00164; 00165, (2019/05/22)
The present disclosure provides compounds, their pharmaceutical compositions, and methods of their use for treating mesenchymally-derived or mesenchymallytransformed cancers, such as breast cancers and sarcomas, and for treating diseases or disorders that are characterized by the expression of vimentin.
QUINAZOLINE DERIVATIVES AS PDE10A ENZYME INHIBITORS
-
Page/Page column 55; 56; 57, (2013/04/24)
This invention is directed to compounds, which are PDE10A enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The pr
